Novavax (NVAX) reported a 3rd Quarter September 2020 loss of $3.21 per share on revenue of $157.0 million. The consensus earnings estimate was $2.36 per share on revenue of $234.2 million. I won't be surprised if NVAX tanks below $50 by 11/20. Do your own due diligence, your risk is 100% your responsibility. Good luck and happy trading friends...
*3x lucky 7s of trading 101*
7pt Trading compass: Price action Volume average Trend momentum Current events Revenue & Earnings Debt / Cash Book value
7 Common mistakes: +5% portfolio trades Bad risk management Emotions & Opinions FOMO Lack of planning & discipline Forgetting restraint Repetitive errors
7 Important tools: Trading View app Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big organized desk Reading books Brokerage UI
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.